Vasiliki Sarli

17PUBLICATIONS
29CO-AUTHORS
Cheminformatics and quantitative structure-activity relationshipsCancer therapy (excl. chemotherapy and radiation therapy)Molecular targetsBiologically active moleculesBiomolecular modelling and design
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (17)

|May 27, 2026
Phenoxazine Derivative ST61 Displays an Oxidative-Stress-Mediated Cytotoxic Activity Against Human Cancer Cells.

|Feb 27, 2026
Novel Active Homo-Aza (Lactam) Steroidal Antimetabolites for the Treatment of Human Pancreatic and Colorectal Cancer.

Konstantinos E Alifieris, Panagiotis Dalezis, Sofia Sagredou

|Nov 03, 2025
Synthesis of novel SRPK1-targeting hybrid compounds incorporating antimetabolites for cancer therapy.

George Leonidis, Ioanna Sigala, Michail Spathakis

|May 14, 2025
Synthesis and Biological Screening of Structurally Modified Phaeosphaeride Analogues.

Konstantinos Rantzios, Oraia-Eirini Chatzimentor, George Leonidis

|Dec 19, 2024
Developing MYC Degraders Bearing the Von Hippel-Lindau Ligand to Target the "Undruggable" MYC.

Christos Siokatas, Alexandra Lampropoulou, Alexandra Smina

|Nov 14, 2024
Development of 2-Aminoadenine-Based Proteolysis-Targeting Chimeras (PROTACs) as Novel Potent Degraders of Monopolar Spindle 1 and Aurora Kinases.

Eleni Sflakidou, Bikash Adhikari, Christos Siokatas

Pageof 3

Frequent Collaborators

6 joint publications

Panayiotis Dalezis

5 joint publications

Dimitrios Trafalis

4 joint publications

Sofia Sagredou

4 joint publications

George Leonidis